Thyronajod Side Effects

Common Thyronajod Side Effects

The most commonly reported Thyronajod side effects (click to view or check a box to report):

Blood Creatinine Increased (3)
Brain Mass (2)
Brain Oedema (2)
Dysgeusia (2)
Facial Paresis (2)
Eyelid Function Disorder (2)
Fallot's Tetralogy (2)
Aphasia (2)
Hyperaesthesia (2)
Tubulointerstitial Nephritis (2)
Oscillopsia (2)
Renal Failure Acute (2)
Neonatal Respiratory Distress Syndrome (2)
Hypoaesthesia Oral (2)
Myoclonus (2)
Nephrosclerosis (1)
Nausea (1)
Maternal Exposure During Pregnancy (1)
Movement Disorder (1)
Nasopharyngitis (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Thyronajod Side Effects Reported to FDA

The following Thyronajod reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Thyronajod on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pain, Femur Fracture, Condition Aggravated, Fall
This is a report of a 85-year-old female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: NA, who was treated with Thyronajod (levothyroxine Sodium, Potassium Iodide) (dosage: NA, start time: May 29, 2009), combined with:
  • Actonel (Oral)
  • Actonel (Oral)
  • Ramipril
  • Amlodipin /00972401/ (amlodipine)
  • Metoprolol Tartrate
and developed a serious reaction and side effect(s). The consumer presented with:
  • Pain
  • Femur Fracture
  • Condition Aggravated
  • Fall
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Thyronajod (levothyroxine Sodium, Potassium Iodide) treatment in female patients, resulting in pain side effect. The patient was hospitalized and became disabled.

Cerebral Venous Thrombosis
This report suggests a potential Thyronajod Cerebral Venous Thrombosis side effect(s) that can have serious consequences. A 55-year-old male patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: thyroidectomy,metastatic renal cell carcinoma,oesophagitis,glaucoma and used Thyronajod (dosage: 150 Mg, 1x/day) starting Jan 01, 2009. Soon after starting Thyronajod the patient began experiencing various side effects, including:
  • Cerebral Venous Thrombosis
Drugs used concurrently:
  • Sunitinib Malate (50 Mg, 1x/day)
  • Pantoprazole Sodium (40 Mg, 1x/day)
  • Azopt (Drops, 2x/day)
The patient was hospitalized. Although Thyronajod demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebral venous thrombosis, may still occur.

Neonatal Respiratory Distress Syndrome, Fallot's Tetralogy, Maternal Exposure During Pregnancy
This Neonatal Respiratory Distress Syndrome, Fallot's Tetralogy, Maternal Exposure During Pregnancy problem was reported by a health professional from GERMANY. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: hypothyroidism,depression,prophylaxis of neural tube defect. On May 12, 2010 this consumer started treatment with Thyronajod (dosage: 50 [?g/d (bis 25) ] / 150 [?g/d ]/ From Week 5: Increased Dose With 50 ?g/d). The following drugs were being taken at the same time:
  • Promethazine (60 [mg/d (30-0-30) ])
  • Fol (0.4 [mg/d ]/ -?, And Preconceptionell)
  • Sertraline Hydrochloride (150 [mg/d (100-0-50) ])
When commencing Thyronajod, the patient experienced the following unwanted symptoms/side effects:
  • Neonatal Respiratory Distress Syndrome
  • Fallot's Tetralogy
  • Maternal Exposure During Pregnancy
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as neonatal respiratory distress syndrome, may become evident only after a product is in use by the general population.

Fallot's Tetralogy, Neonatal Respiratory Distress Syndrome
This is a report of a male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Thyronajod (dosage: Unk) starting Mar 27, 2010. Concurrently used drugs:
  • Sertraline Hydrochloride (150 Mg/day)
  • Fol 400 (0.4 Mg/day)
  • Promethazine (60 Mg/day)
Soon after that, the consumer experienced the following side effects:
  • Fallot's Tetralogy
  • Neonatal Respiratory Distress Syndrome
The patient was hospitalized. This opens a possibility that Thyronajod treatment could cause the above reactions, including fallot's tetralogy, and some male subjects may be more susceptible.

Placenta Praevia Haemorrhage
A 29-year-old female patient (weight: NA) from GERMANY with the following symptoms/conditions: hypothyroidism,prophylaxis of neural tube defect,depression started Thyronajod treatment (dosage: 25 Ug, 2x/day) on May 12, 2010. Soon after starting Thyronajod treatment, the subject experienced various side effects, including:
  • Placenta Praevia Haemorrhage
Concurrently used drugs:
  • Fol 400 (0.4 Mg, 1x/day)
  • Promethazine (30 Mg, 2x/day)
This finding indicates that some female patients could be more vulnerable to Thyronajod.

Nephrosclerosis, Tubulointerstitial Nephritis, Ileus, Blood Creatinine Increased
A 42-year-old male patient from GERMANY (weight: NA) experienced symptoms, such as: NA and was treated with Thyronajod(dosage: 75 Ug, Qd). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Nephrosclerosis
  • Tubulointerstitial Nephritis
  • Ileus
  • Blood Creatinine Increased
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Thyronajod efficacy:
  • Amisulpride (400 Mg, Twice Daily)
  • Bisoprolol Fumarate (5 Mg, Bid)
  • Clozapine (100 Mg, Bid)
  • Eprosartan (600 Mg, Qd)

Brain Mass, Myoclonus, Oscillopsia, Brain Oedema, Abasia, Back Pain, Blood Creatinine Increased, Renal Failure Acute, Aphasia
In this report, Thyronajod was administered for the following condition: hypothyroidism,epilepsy,multiple sclerosis.A female consumer from GERMANY (weight: NA) started Thyronajod treatment (dosage: Unk) on Sep 20, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Brain Mass
  • Myoclonus
  • Oscillopsia
  • Brain Oedema
  • Abasia
  • Back Pain
  • Blood Creatinine Increased
  • Renal Failure Acute
  • Aphasia
A possible interaction with other drugs could have contributed to this reaction:
  • Keppra
  • Fty 720 (0.5mg Daily)
  • Sulfadiazine
  • Diovan
  • Nebivolol
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Thyronajod treatment could be related to the listed above side effect(s).

Nausea, Vomiting
This is a report of the following Thyronajod side effect(s):
  • Nausea
  • Vomiting
A female patient from GERMANY (weight: NA) presented with the following condition: NA and received a treatment with Thyronajod (dosage: NA) starting: Aug 10, 2010.The following concurrently used drugs could have generated interactions:
  • Lapatinib (1500mg Per Day)
The patient was hospitalized.This report suggests that a Thyronajod treatment could be associated with the listed above side effect(s).

Brain Mass, Aphasia, Dysaesthesia, Hyperaesthesia, Vertigo, Renal Failure Acute, Hemiparesis, Hypertonia, Brain Oedema
This Thyronajod report was submitted by a female consumer from GERMANY (weight: NA). The patient was diagnosed with: hypothyroidism,epilepsy and Thyronajod was administered (dosage: Unk) starting: Sep 20, 2010. The consumer developed a set of symptoms:
  • Brain Mass
  • Aphasia
  • Dysaesthesia
  • Hyperaesthesia
  • Vertigo
  • Renal Failure Acute
  • Hemiparesis
  • Hypertonia
  • Brain Oedema
Other drugs used simultaneously:
  • Keppra
  • Sulfadiazine
  • Diovan
  • Fty 720 (0.5mg Daily)
  • Nebivolol
The patient was hospitalized.Those unexpected symptoms could be linked to a Thyronajod treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Central Nervous System Lesion, Myoclonus, Oscillopsia, Paraesthesia, Epstein-barr Virus Infection, Hyperaesthesia, Movement Disorder, Blood Creatinine Increased, Tubulointerstitial Nephritis
This is a report of a possible correlation between Thyronajod use and the following symptoms/side effect(s):
  • Central Nervous System Lesion
  • Myoclonus
  • Oscillopsia
  • Paraesthesia
  • Epstein-barr Virus Infection
  • Hyperaesthesia
  • Movement Disorder
  • Blood Creatinine Increased
  • Tubulointerstitial Nephritis
which could contribute to an assessment of Thyronajod risk profile.A female consumer from GERMANY (weight: NA) was suffering from hypothyroidism,hypertension,epilepsy and was treated with Thyronajod (dosage: Unk) starting Sep 20, 2010.Other concurrent medications:
  • Nebivolol
  • Keppra
  • Diovan
  • Fty 720 (0.5mg Daily)
  • Sulfadiazine
The patient was hospitalized.

Dysgeusia, Eyelid Function Disorder, Facial Paresis, Hypoaesthesia Oral, Nasopharyngitis
A 30-year-old female patient from GERMANY (weight: NA) presented with the following symptoms: NA and after a treatment with Thyronajod (dosage: NA) experienced the following side effect(s):
  • Dysgeusia
  • Eyelid Function Disorder
  • Facial Paresis
  • Hypoaesthesia Oral
  • Nasopharyngitis
The treatment was started on Jul 25, 2006. Thyronajod was used in combination with the following drugs:
  • Lamisil (Unk, Unk)
This report could alert potential Thyronajod consumers.

Dysgeusia, Eyelid Function Disorder, Facial Paresis, Hypoaesthesia Oral
In this report, a 30-year-old female patient from GERMANY (weight: NA) was affected by a possible Thyronajod side effect.The patient was diagnosed with NA. After a treatment with Thyronajod (dosage: NA, start date: Jul 25, 2006), the patient experienced the following side effect(s):
  • Dysgeusia
  • Eyelid Function Disorder
  • Facial Paresis
  • Hypoaesthesia Oral
The following simultaneously used drugs could have led to this reaction:
  • Lamisil (Unk, Unk)
The findings here stress that side effects should be taken into consideration when evaluating a Thyronajod treatment.

This is a report of a male patient from GERMANY (weight: NA), who used Thyronajod 125 (dosage: Daily Dose: 125 Milligram(s)) for a treatment of secondary hyperthyroidism,osteoporosis. After starting a treatment on Feb 01, 2005, the patient experienced the following side effect(s):
  • Periostitis
The following drugs could possibly have interacted with the Thyronajod 125 treatment
  • Androtop Gel
  • Androtop Gel (Daily Dose: 25 Milligram(s))
Taken together, these observations suggest that a Thyronajod 125 treatment could be related to side effect(s), such as Periostitis.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Thyronajod Side Effects

    Did You Have a Thyronajod Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Thyronajod for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Thyronajod Safety Alerts, Active Ingredients, Usage Information

    More About Thyronajod

    Side Effects reported to FDA: 13

    Thyronajod safety alerts: No

    Reported hospitalizations: 7

    Latest Thyronajod clinical trials

    Thyronajod Reviews

    No reviews, be a first to report a side effect via side effect reporting form